Tyloxapol: Difference between revisions
Content deleted Content added
{{Cough and cold preparations}} and infobox |
cas |
||
| Line 2: | Line 2: | ||
| IUPAC_name = |
| IUPAC_name = |
||
| image = |
| image = |
||
| CAS_number = |
| CAS_number = 25301-02-4 |
||
| ATC_prefix = R05 |
| ATC_prefix = R05 |
||
| ATC_suffix = CA01 |
| ATC_suffix = CA01 |
||
Revision as of 02:38, 17 July 2007
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.209.660 |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type; used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. Tyloxapol, when injected IP, also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |